Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamid and ATG for allogeneic stem cell transplantation in patients with relapsed or high-risk acute myeloic leukaemia

被引：0
|
作者：
Chemnitz, J. [1 ]
Holtik, U. [1 ]
Theurich, S. [1 ]
Shimabokuro-Vornhagen, A. [1 ]
Hallek, M. [1 ]
Scheid, C. [1 ]
机构：
[1] Stem Cell Transplantat Program Cologne, Cologne, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [1] Intermediate intensity conditioning regimen containing FLAMSA, Treosulfan, Cyclophosphamid and ATG for allogeneic stem cell transplantation in patients with relapsed or high-risk acute myeloic leukaemia
    Chemnitz, J.
    Holtik, U.
    Theurich, S.
    Shimabokuro-Vomhagen, A.
    Krause, A.
    Hallek, M.
    Scheid, C.
    ONKOLOGIE, 2010, 33 : 166 - 166
  • [2] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Chemnitz, Jens Marcus
    von Lilienfeld-Toal, Marie
    Holtick, Udo
    Theurich, Sebastian
    Shimabukuro-Vornhagen, Alexander
    Krause, Anke
    Brossart, Peter
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 47 - 55
  • [3] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Jens Marcus Chemnitz
    Marie von Lilienfeld-Toal
    Udo Holtick
    Sebastian Theurich
    Alexander Shimabukuro-Vornhagen
    Anke Krause
    Peter Brossart
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2012, 91 : 47 - 55
  • [4] High antileukaemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukaemia in first complete remission
    Schmid, C.
    Schleuning, M.
    Tischer, J.
    Ledderose, G.
    Gerbitz, A.
    Oruzio, D.
    Hentrich, M.
    Kolb, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S6 - S6
  • [5] Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients
    Baronciani, Donatella
    Rambaldi, Alessandro
    Iori, Anna Paola
    Di Bartolomeo, Paolo
    Pilo, Federica
    Pettinau, Martina
    Depau, Cristina
    Mico, Caterina
    Santarone, Stella
    Angelucci, Emanuele
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (09) : 717 - 720
  • [6] Treatment of high-risk acute lymphoblastic leukaemia relapse after allogeneic stem cell transplantation with secondary reduced-intensity conditioning regimen allogeneic transplantation or immunotherapy
    Piatkowska-Jakubas, B
    Mensah, P
    Hawrylecka, D
    Krawczyk, J
    Skotnicki, AB
    BONE MARROW TRANSPLANTATION, 2004, 33 : S329 - S329
  • [7] High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission
    C Schmid
    M Schleuning
    M Hentrich
    G E Markl
    A Gerbitz
    J Tischer
    G Ledderose
    D Oruzio
    W Hiddemann
    H-J Kolb
    Bone Marrow Transplantation, 2008, 41 : 721 - 727
  • [8] High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission
    Schmid, C.
    Schleuning, M.
    Hentrich, M.
    Markl, G. E.
    Gerbitz, A.
    Tischer, J.
    Ledderose, G.
    Oruzio, D.
    Hiddemann, W.
    Kolb, H-J
    BONE MARROW TRANSPLANTATION, 2008, 41 (08) : 721 - 727
  • [9] Allogeneic blood stem cell transplantation of high-risk patients after conditioning with treosulfan and fludarabine
    Casper, J
    Wilhelm, S
    Steiner, B
    Wolff, D
    Grobe, N
    Hähling, D
    Hartung, G
    Hilgendorf, I
    Lück, A
    Junghanss, C
    Kahl, C
    Baumgart, J
    Pichlmeier, U
    Freund, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (38) : 2125 - 2129
  • [10] Clofarabine/Ara-C treatment combined with reduced-intensity conditioning for allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute leukaemia
    Buchholz, S.
    Krauter, J.
    Dammann, E.
    Ehrlich, S.
    Port, M.
    Weissinger, E.
    Stadler, M.
    Eder, M.
    Ganser, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S207 - S207
12345